Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | White Papers
Search Refinements

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
76-90 of 147 results
How 3D Medical Animation Benefits The Healthcare Industry
| By Polygon Medical Animation
From the earliest sketches and drawings of the human anatomy by Leonardo da Vinci to the world of modern visual communication, exploring the wonders of science has never been so beautifully revealed since the dawn of 3D. In the healthcare industry, where customer demands are changing and ever increasing, they have embraced the use of 3D medical animation as a new and effective form of communication to keep abreast with the times.
Drug Research > Drug Discovery & Development > White Papers
TMA Toolbox: A Complete On-Line Management Application For Tissue Microarray
| By Path XL
The tissue microarray (TMA) was first described by Kononen in 1998, and represents a high-throughput technology for the assessment of histology-based specimens and can include such modalities as H&E sections, immunohistochemistry and fluorescent in-situ hybridization (FISH).
Drug Research > Drug Discovery & Development > White Papers
PATHXL Simulator: An On-line Diagnostic Training and Simulation Package Designed
| By Path XL
Educators and pathology professionals have realized the gap between the safe enclosed learning space of the classroom and the diversity of life experiences that exist in the reporting room. There is a desire to extend the fundamental limitations of one-on-one microscope training. It is into this arena that diagnostic simulation is making an impact.
Drug Research > Drug Discovery & Development > White Papers
Picture Perfect - Bioimaging Digital Pathology
| By Path XL
Digital pathology is revolutionising the fi eld of bioimaging by reducing operational costs, improving quality and enabling researchers to fast-track the discovery of novel tissue-based biomarkers for companion diagnostics through automated tissue imaging
Drug Research > Drug Discovery & Development > White Papers
DIA EUROPE CONFERENCES AND WORKSHOPS 2013-2014
| By Drug Information Association
For more information and a complete listing of all DIA conferences, please visit: www.diahome.org > click on Meetings & Training
Call DIA Europe on +41 61 225 51 51 or email: diaeurope@diaeurope.org

Drug Research > Drug Discovery & Development > White Papers
Combination Products Workshop, 17th October 2013, Basel, Switzerland
| By Drug Information Association
This one-day workshop will provide delegates with an understanding of the current regulatory framework for drug/device combinations and companion diagnostics, and of the anticipated impact of the revision of the European medical device and In-Vitro Diagnostics (IVD) legislation.
Drug Research > Drug Discovery & Development > White Papers
14th DIA Conference on European Electronic Document Management (eDM) 20–22 November 2013 Dublin, Ireland
| By Drug Information Association
During the middle ages alchemists were looking for the Philosopher’s Stone. As it was believed, the mythical substance could not only turn lead into gold, but also prolong life and restore youth. Although the goal was never achieved, alchemy paved the way to scientific methods and so to the medical advances of today. This has transformed our lives in more than one way.
Drug Research > Drug Discovery & Development > White Papers
7th DIA/EFGCP/EMA Medicines for Children Conference, 24th-25th September 2013, London, UK
| By Drug Information Association
This year’s DIA/EFGCP/EMA paediatric conference will take place in the seventh year of the EU Paediatric Regulation. Over 1’000 Paediatric Investigation Plans (PIPs) have been submitted so far and paediatric aspects are now an integrated part of drug development.
Drug Research > Drug Discovery & Development > White Papers
Joint DIA/MHRA Statistics Workshop 2nd-4th October 2013, London, United Kingdom
| By Drug Information Association
Life-cycle management is a widely accepted concept for the development and marketing of medicines. At each step of this process, pre- and post-licensing, statisticians work to develop methods that can improve efficiency and can enhance decision-making through optimal study design, analysis and inference. The workshop aims to discuss the latest developments in statistical methodology and decision-making in exploratory development, confirmatory development, licensing decisions and management of benefits and risks post-licensing.
Drug Research > Drug Discovery & Development > White Papers
7th Annual DIA Clinical Forum Dublin, Ireland on 8–9 October 2013.
| By Drug Information Association
The DIA Clinical Forum is known as a conference that brings together experts from different fields, including data management, clinical operations, drug safety, medical affairs, medical information and medical writing. Experts share their expertise and experience with people from other companies and disciplines. Making the presentations and workshops relevant to the day to day work of participants has always been the focus of previous programme committees – and I am glad to confirm that this won’t be any different this year.
Drug Research > Drug Discovery & Development > White Papers
10th Middle East Regulatory Conference (MERC) 2013. Collaboration, Partnership and Interaction: Authority and Industry
| By Drug Information Association
This is the 10th DIA Middle East Regulatory Conference in partnership with the Middle East Regulatory Network (MERN). The MERN is an ad hoc regional network of the EFPIA (European Federation of Pharmaceutical Industries and Associations). The MERN works in partnership with regulatory authorities and the pharmaceutical industry in the Middle East to develop legislation and regulatory practices that enable patients to have access to good quality medicines, including innovative medicines.
Drug Research > Drug Discovery & Development > White Papers
26th Annual EuroMeeting Vienna 2014, 25th - 27th March 2014 ACV, Vienna, Austria
| By Drug Information Association
The Annual EuroMeeting is DIA’s largest conference in Europe, attracting more than 3,000 professionals from industry, government, academia, as well as patient groups and students. It is unique in the quality of its content and speakers, and in the opportunity to network with like minded professionals, regulators and thought leaders. Early-bird rate for DIA Members – register by Tuesday, 11 February 2014 and save €185! Register onsite at DIA 2013 to save an additional €100!
Drug Research > Drug Discovery & Development > White Papers
IMD-A Systems: Ideal Training Tools
| By Azbil BioVigilant
Many pharmaceutical, biotechnology, ophthalmology and food and beverage companies manufacture and package their products in cleanrooms or other highly controlled environments using operating procedures designed to minimize contamination of products with foreign materials. Microbial contamination, in particular, is a serious concern because of the potential danger to the health of recipients.
Drug Research > Drug Discovery & Development > White Papers
Real-Time Investigation Services Using Instantaneous Microbial Detection
| By Azbil BioVigilant
In the pharmaceutical industry, product contamination poses a serious risk to manufacturing operations. If an out-of-specification event occurs, finding the root cause, taking remediation steps, and getting the manufacturing line back to full operational levels is critically important. Downtime on any manufacturing line can lead to a significant impact on the financial performance of the company.
Drug Research > Drug Discovery & Development > White Papers
Instantaneous Microbial Monitoring of Compressed Gases
| By Azbil BioVigilant
Compressed air and other gases are used for a range of applications in pharmaceutical and food and beverage manufacturing, including applications involving direct product contact. As such, these gases should be monitored for levels of microbial and particulate contamination. Azbil BioVigilant’s IMD-A® systems are useful tools for microbial monitoring that offer the advantages of increased sensitivity, instantaneous detection, and real-time reporting, as compared to traditional growth-based methods.
Drug Research > Drug Discovery & Development > White Papers
76-90 of 147 results